Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences?

about

Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences?

Item

http://www.wikidata.org/entity/Q47250639

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Delayed methotrexate eliminati ...... gs, and clinical consequences?

@en

Delayed methotrexate eliminati ...... gs, and clinical consequences?

@nl

type

Item

label

Delayed methotrexate eliminati ...... gs, and clinical consequences?

@en

Delayed methotrexate eliminati ...... gs, and clinical consequences?

@nl

prefLabel

Delayed methotrexate eliminati ...... gs, and clinical consequences?

@en

Delayed methotrexate eliminati ...... gs, and clinical consequences?

@nl

P1476

Delayed methotrexate eliminati ...... gs, and clinical consequences?

@en

P2093

Amandine Baudouin

http://www.w3.org/2001/XMLSchema#string

Anne Gaelle Caffin

http://www.w3.org/2001/XMLSchema#string

Aurore Gouraud

http://www.w3.org/2001/XMLSchema#string

Catherine Rioufol

http://www.w3.org/2001/XMLSchema#string

Clémentine Sarkozy

http://www.w3.org/2001/XMLSchema#string

Emilie Henin

http://www.w3.org/2001/XMLSchema#string

Emmanuel Bachy

http://www.w3.org/2001/XMLSchema#string

Estelle Bourbon

http://www.w3.org/2001/XMLSchema#string

Fadhela Bouafia-Sauvy

http://www.w3.org/2001/XMLSchema#string

Gilles Salles

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update

Pharmacokinetic interaction between high-dose methotrexate and amoxycillin

Prediction of creatinine clearance from serum creatinine

Suspected methotrexate toxicity from omeprazole: a case review of carboxypeptidase G2 use in a methotrexate-experienced patient with methotrexate toxicity and a review of the literature.

High incidence of methotrexate associated renal toxicity in patients with lymphoma: a retrospective analysis.

Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies.

Retrospective evaluation of methotrexate elimination when co-administered with proton pump inhibitors

Active proton secretion and potassium absorption in the rabbit outer medullary collecting duct. Functional evidence for proton-potassium-activated adenosine triphosphatase.

Understanding and managing methotrexate nephrotoxicity.

Co-administration of proton pump inhibitors delays elimination of plasma methotrexate in high-dose methotrexate therapy.

P31

scholarly article

P356

10.1002/HON.2479

http://www.w3.org/2001/XMLSchema#string

P50

Thierry Vial

Florence Ranchon

P577

2017-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28983943

http://www.w3.org/2001/XMLSchema#string